Energous (WATT) 10-K 30 Mar 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Mar. 30, 2015	Jun. 30, 2014
Document Information [Line Items]
Entity Registrant Name	Energous Corp
Entity Central Index Key	1575793
Current Fiscal Year End Date	-19
Entity Filer Category	Smaller Reporting Company
Trading Symbol	WATT
Entity Common Stock, Shares Outstanding		12,796,502
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$99,383,907

BALANCE_SHEETS

BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$31,494,592	$1,953,780
Prepaid expenses and other current assets	416,580	127,197
Prepaid rent, current	80,784	0
Total current assets	31,991,956	2,080,977
Property and equipment, net	1,515,299	189,612
Prepaid rent, non-current	299,020	0
Deferred offering costs	0	88,319
Other assets	22,648	6,959
Total assets	33,828,923	2,365,867
Current liabilities:
Accounts payable	1,716,011	361,038
Accrued expenses	792,349	243,623
Convertible promissory notes, net	0	829,298
Derivative liabilities	0	6,277,000
Total current liabilities	2,508,360	7,710,959
Commitments and contingencies
Stockholders' equity (deficit)
Preferred Stock, $0.00001 par value, 10,000,000 and 0 shares authorized at December 31, 2014 and December 31, 2013, respectively; no shares issued or outstanding.	0	0
Common Stock, $0.00001 par value, 50,000,000 and 40,000,000 shares authorized at December 31, 2014 and December 31, 2013, respectively; 12,781,502 and 2,708,217 shares issued and outstanding at December 31, 2014 and December 31, 2013, respectively.	127	27
Additional paid-in capital	82,465,914	197,249
Accumulated deficit	-51,145,478	-5,542,368
Total stockholders' equity (deficit)	31,320,563	-5,345,092
Total liabilities and stockholders' equity (deficit)	$33,828,923	$2,365,867

BALANCE_SHEETS_Parenthetical

BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	0
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	50,000,000	40,000,000
Common stock, shares issued	12,781,502	2,708,217
Common stock, shares outstanding	12,781,502	2,708,217

STATEMENTS_OF_OPERATIONS

STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Operating expenses:
Derivative instrument issuance	$0	$887,062
Research and development	12,511,647	2,109,890
General and administrative	5,059,703	1,204,896
Marketing	2,803,359	233,622
Loss from operations	-20,374,709	-4,435,470
Other (expense) income:
Change in fair value of derivative liabilities	-26,265,177	-177,000
Interest, net	-1,024,774	-908,611
Loss on retirement of fixed assets	-22,818	0
Gain on debt extinguishment	2,084,368	0
Total	-25,228,401	-1,085,611
Net loss	($45,603,110)	($5,521,081)
Basic and diluted net loss per common share	($5.75)	($2.11)
Weighted average shares outstanding, basic and diluted	7,933,791	2,617,022

STATEMENT_OF_CHANGES_IN_STOCKH

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance at Dec. 31, 2012	($11,287)	$19	$9,981	($21,287)
Balance (in shares) at Dec. 31, 2012		1,924,813
Common stock sold on January 28, 2013 to founder at $0.0052 per share	417	1	416	0
Common stock sold on January 28, 2013 to founder at $0.0052 per share (in shares)		80,201
Common stock sold on March 4, 2013 to affiliate of a director at $0.24 per share	160,000	7	159,993	0
Common stock sold on March 4, 2013 to affiliate of a director at $0.24 per share (in shares)		668,338
Common stock sold on May 7, 2013 to third party investor at $0.24 per share	4,800	0	4,800	0
Common stock sold on May 7, 2013 to third party investor at $0.24 per share (in shares)		20,051
Restricted common stock sold on May 14, 2013 under the 2013 Stock Plan of DvineWave, Inc., to consultant at $0.40 per share	35,464	1	35,463	0
Restricted common stock sold on May 14, 2013 under the 2013 Stock Plan of DvineWave, Inc., to consultant at $0.40 per share (in shares)		88,882
Repurchase and retirement of restricted common stock from consultant on November 30, 2013 at $0.40 per share	-29,553	-1	-29,552	0
Repurchase and retirement of restricted common stock from consultant on November 30, 2013 at $0.40 per share (in shares)		-74,068
Stock-based compensation	16,148	0	16,148	0
Extinguishment of derivative for consulting warrant and financing warrant on June 25, 2014	0
Shares issued to landlord for prepaid rent	0
Net loss	-5,521,081	0	0	-5,521,081
Balance at Dec. 31, 2013	-5,345,092	27	197,249	-5,542,368
Balance (in shares) at Dec. 31, 2013		2,708,217
Stock-based compensation - stock options	1,333,943	0	1,333,943	0
Stock-based compensation - IR consultant warrant	263,972	0	263,972	0
Stock-based compensation - consultant restricted stock units ("RSUs")	900,063	0	900,063	0
Stock-based compensation - shares issued to consultant for services rendered	50,000	0	50,000	0
Stock-based compensation - shares issued to consultant for services rendered (in shares)		5,353
Issuance of shares to strategic investor, net of commission expense	900,000	2	899,998	0
Issuance of shares to strategic investor, net of commission expense (in shares)		210,527
Initial public offering on April 2, 2014, net of underwriter's discount and offering costs of $2,816,149	24,783,851	46	24,783,805	0
Initial public offering on April 2, 2014, net of underwriter's discount and offering costs of $2,816,149 (in shares)		4,600,000
Conversion of convertible notes on April 2, 2014	26,790,177	19	26,790,158	0
Conversion of convertible notes on April 2, 2014 (in shares)		1,930,128
Sale of IPO Underwriter Warrant on April 2, 2014	1,000	0	1,000	0
Extinguishment of derivative for consulting warrant and financing warrant on June 25, 2014	5,752,000	0	5,752,000	0
Shares issued to landlord for prepaid rent	500,000	0	500,000	0
Shares issued to landlord for prepaid rent (in shares)		41,563
Secondary offering on December 15, 2014, net of underwriter's discount and offering costs of $2,006,239	20,993,759	33	20,993,726	0
Secondary offering on December 15, 2014, net of underwriter's discount and offering costs of $2,006,239 (in shares)		3,285,714
Net loss	-45,603,110	0	0	-45,603,110
Balance at Dec. 31, 2014	$31,320,563	$127	$82,465,914	($51,145,478)
Balance (in shares) at Dec. 31, 2014		12,781,502

STATEMENT_OF_CHANGES_IN_STOCKH1

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Common Stock Issued To Third Party Investor Per Share Price		$0.24
Common Stock Issued To Founder Per Share Price		$0.01
Common Stock Issued To Affiliate Director Per Share Price		$0.24
Restricted Common Stock Issued To Consultant Per Share Price		$0.40
Repurchase And Retirement Of Restricted Common Stock From Consultant Per Share Price		$0.40
Payments of Stock Issuance Costs	$2,816,149
Partners' Capital Account, Public Sale of Units Net of Offering Costs	$2,006,239

STATEMENTS_OF_CASH_FLOWS

STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net loss	($45,603,110)	($5,521,081)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	371,189	4,717
Loss on retirement of fixed assets	22,818	0
Stock based compensation	2,547,978	16,148
Amortization of debt discount	964,851	705,289
Warrant expense	0	724,000
Write-off of abandoned trademark	0	4,725
Gain on conversion of notes payable and accrued interest	-2,084,368	0
Change in fair market value of derivative liabilities	26,265,177	177,000
Amortization of prepaid rent from stock issuance to landlord	20,196
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	-289,383	-127,197
Other assets	-15,689	-6,959
Accounts payable	1,354,973	359,163
Accrued expenses	838,945	233,217
Net cash used in operating activities	-15,606,423	-3,430,978
Cash flows from investing activities:
Purchase of property and equipment	-1,619,694	-194,329
Costs of trademark	0	-4,725
Net cash used in investing activities	-1,619,694	-199,054
Cash flows from financing activities:
Proceeds from the sale of common stock	0	200,681
Payment of deferred offering cost	0	-88,319
Repurcharse of restricted common stock	0	-29,553
Proceeds from IPO, net of underwriter's discount and offering expenses	24,872,170	0
Proceeds from secondary offering, net of underwriter's discount and offering expenses	20,993,759
Proceeds from the sale of senior secured convertible notes	0	5,500,009
Proceeds from the sale of stock to strategic investor, net	900,000	0
Sale of warrant to IPO underwriter	1,000	0
Net cash provided by financing activities	46,766,929	5,582,818
Net increase in cash and cash equivalents	29,540,812	1,952,786
Cash and cash equivalents - beginning	1,953,780	994
Cash and cash equivalents - ending	31,494,592	1,953,780
Supplemental disclosure of non-cash financing activities:
Decrease in deferred offering costs charged to the IPO	88,319	0
Common stock issued upon conversion of notes payable and accrued interest payable	26,790,177	0
Increase in additional paid in capital upon extinguishment of derivative liability for warrants	5,752,000	0
Common stock issued to landlord for tenant improvements of $100,000 and prepaid rent of $400,000	$500,000	$0

STATEMENTS_OF_CASH_FLOWS_Paren

STATEMENTS OF CASH FLOWS (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2014
Payments for Tenant Improvements	$100,000
Payments for Rent	$400,000

Business_Organization_Nature_o

Business Organization, Nature of Operations	12 Months Ended
	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1 - Business Organization, Nature of Operations
	Energous Corporation (f/k/a DvineWave Inc.) (the “Company”) was incorporated in Delaware on October 30, 2012 (inception). The Company is a technology company focused on developing technology that can enable wire-free charging of electronic devices at a distance and with complete mobility. The Company is developing solutions that enable wire-free transmission of energy from a transmitter to multiple receivers at distances of up to fifteen (15) feet. The Company is developing multiple generations of transmitter and receiver application specific integrated circuit chips (“ASICs) whose designs will be licensed to customers, and that we believe will optimize our technology reducing size and cost, while increasing performance to a level that we believe will allow for them to be integrated into low-power devices, eliminating the need for a charging cord or pad to maintain charge. The Company submitted its first ASIC design for wafer fabrication in November 2013. Since then, the Company submitted transmitter and receiver ASIC designs to its wafer fabricator for production. Two of these ASICs were used to demonstrate its WattUp technology in prototypical consumer products in conjunction with its strategic partners at the Consumer Electronics Show in January 2015. Additional ASICs are under development and two of these ASICs have entered the fabrication stage.
	On January 2, 2014, the board of directors and stockholders approved the name change for the Company to Energous Corporation from DvineWave Inc.
	Effective March 26, 2014, pursuant to authority granted by the stockholders and the Board of Directors of the Company, the Company implemented a 1-for-3.99 reverse split of the Company’s issued and outstanding common stock (the “Reverse Split”). All share and per share information in these financial statements have been retroactively adjusted to reflect the Reverse Split.

Liquidity_and_Management_Plans

Liquidity and Management Plans	12 Months Ended
	Dec. 31, 2014
Liquidity And Management Plan Disclosure [Abstract]
Liquidity And Management Plan Disclosure [Text Block]	Note 2 – Liquidity and Management Plans
	As of December 31, 2014, the Company had not yet completed the development of its product and had not yet recorded any revenues. Since inception, the Company’s primary activities have consisted of developing its technology, developing its business plan, raising capital, relocating to a larger facility and recruiting and hiring its workforce and executive team. To date, these activities have been funded primarily through the sale of Senior Secured Convertible Notes (“Convertible Notes”) (See Note 6- Private Placement), the funding of the Company’s initial public offering (“IPO”), which was consummated on April 2, 2014 (See Note 8 – Stockholders’ Equity (Deficit)), the sale of the Company common stock to a strategic investor (See Note 8 – Stockholders’ Equity (Deficit)), the issuance of common stock to our landlord (See Note 7 - Commitments and Contingencies) and the funding of the Company’s secondary offering which was consummated on December 15, 2014 (See Note 8 – Stockholder’s Equity (Deficit)).
	The Company has not generated revenues since its inception and had net losses of $45,603,110 and $5,521,081 for the years ended December 31, 2014 and 2013, respectively.
	As of December 31, 2014, the Company had cash on hand of $31,494,592. In April 2014, the Company completed its IPO of 4,600,000 shares of common stock through which the Company raised net proceeds of approximately $24.8 million. In connection with the completion of the IPO, the Company’s outstanding convertible notes and interest accrued thereon were converted into 1,833,336 and 96,792 shares, respectively, of common stock, thus extinguishing the debt associated with the notes. On April 4, 2014, the Company issued 210,527 shares of common stock to a strategic investor upon the receipt of net proceeds of $900,000 ($300,000 received on March 27, 2014, $700,000 received on April 4, 2014 less $100,000 to MDB Capital Group as a commission ). On September 10, 2014, the Company issued 41,563 shares of common stock to the Company’s landlord as prepaid rent and tenant improvements. On November 12, 2014, the Company issued 5,353 shares of common stock to a search firm for services associated with recruiting certain employees. In December 2014, the Company completed a secondary offering of 3,285,714 shares of common stock through which the Company raised net proceeds of approximately $21.0 million. The Company expects that cash on hand as of December 31, 2014 will be sufficient to fund the Company’s operations into the second quarter of 2016.
	Research and development of new technologies is, by its nature, unpredictable.  Although the Company will undertake development efforts with commercially reasonable diligence, there can be no assurance that our available resources including the net proceeds from the Company’s recently completed IPO, secondary offering, and strategic investor financing will be sufficient to enable it to develop and obtain regulatory approval of its technology to the extent needed to create future revenues to sustain its operations.  The Company expects that it may choose to pursue additional financing, depending upon the market conditions, which could include follow-on equity offerings, debt financing, co-development agreements or other alternatives. Should the Company choose to pursue additional financing, there is no assurance that the Company would be able to do so on terms that it would find acceptable.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 3 – Summary of Significant Accounting Policies
	Basis of Presentation
	The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”).
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements as well as the reported expenses during the reporting periods.
	The Company’s significant estimates and assumptions include the valuation of the Company’s common stock, the valuation of stock-based compensation instruments and the valuation of derivative financial instruments, the amortization of deferred financing costs, the useful lives of long-lived assets, and income tax expense. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Although the Company believes that its estimates and assumptions are reasonable, they are based upon information available at the time the estimates and assumptions were made. Actual results could differ from those estimates.
	Research and Development
	Research and development expenses are charged to operations as incurred. For internally developed patents, all patent application costs are expensed as incurred as research and development expense. Patent application costs, generally legal costs, are expensed as research and development costs until such time as the future economic benefits of such patents become more certain. The Company incurred research and development costs of $12,511,647 and $2,109,890 for the years ended December 31, 2014 and 2013, respectively.
	Income Taxes
	Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. As of December 31, 2014, no liability for unrecognized tax benefits was required to be reported. The guidance also discusses the classification of related interest and penalties on income taxes. The Company’s policy is to record interest and penalties on uncertain tax positions as a component of income tax expense. No interest or penalties were recorded during the years ended December 31, 2014 and 2013.
	Net Income (Loss) Per Common Share
	Basic net income (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and warrants (using the treasury stock method), the vesting of restricted stock units (“RSUs”), the exercise and/or conversion of the Company’s convertible notes (using the if-converted method). The computation of diluted loss per share excludes potentially dilutive securities of 3,261,360 and 3,525,904 for the years ended December 31, 2014 and 2013, respectively, because their inclusion would be antidilutive.
	Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net income (loss) per share because the effect of their inclusion would have been anti-dilutive.
		For the Year Ended
		December 31,
		2014		2013
	Convertible Notes – principal		-		2,650,858
	Convertible Notes – accrued interest		-		100,224
	Consulting Warrant to purchase common stock		278,228		278,228
	Financing Warrant to purchase common stock		152,778		220,905
	IPO Warrants  to purchase common stock		460,000		-
	IR Consulting Warrant		36,000		-
	Options to purchase common stock		1,607,075		275,689
	RSUs		727,279		-
	Total potentially dilutive securities		3,261,360		3,525,904
	Fair Value Measurements
	The carrying amounts of cash and cash equivalents, accounts payable and accrued expenses, approximate fair value due to the short-term nature of these instruments. Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:
	Level 1	Quoted prices in active markets for identical assets or liabilities.
	Level 2	Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.
	Level 3	Significant unobservable inputs that cannot be corroborated by market data.
	The assets or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. The following table provides a summary of the liabilities that are measured at fair value on a recurring basis.
						Quoted
				Quoted Prices		Prices for
				in Active		Similar
				Markets for		Assets or
				Identical		Liabilities in		Significant
				Assets or		Active		Unobservable
				Liabilities		Markets		Inputs
		Total		(Level 1)		(Level 2)		(Level 3)
	Derivative Liabilities:
	December 31, 2013:
	Conversion Feature	$	5,573,000	$	-	$	-	$	5,573,000
	Financing Warrant		175,000		-		-		175,000
	Consulting Warrant		529,000		-		-		529,000
	Total	$	6,277,000	$	-	$	-	$	6,277,000
	As of December 31, 2014, the Company no longer had financial instruments which were derivative liabilities.
	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:
		For the Year Ended
		December 31, 2014
	Beginning balance	$	6,277,000
	Change in fair value of conversion feature and warrants		26,265,177
	Extinguishment of derivative liability upon conversion of Convertible Notes		-26,790,177
	Extinguishment of derivative liability upon modification of Financing Warrant		-1,733,000
	Extinguishment of derivative liability upon modification of Consulting Warrant		-4,019,000
	Ending balance	$	-
	The conversion feature of the Convertible Notes immediately prior to conversion was measured at fair value using a Monte Carlo simulation (which also represented the intrinsic value of the conversion feature) and was classified within Level 3 of the valuation hierarchy. The warrant liabilities for the Financing Warrant and the Consulting Warrant, immediately prior to modification were measured at fair value using a Monte Carlo simulation and were classified within Level 3 of the valuation hierarchy. The significant assumptions and valuation methods that the Company used to determine fair value and the change in fair value of the Company’s derivative financial instruments are discussed in Note 6 – Private Placement.
	Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the derivative liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s Interim Chief Financial Officer determined its valuation policies and procedures. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s Interim Chief Financial Officer with support from the Company’s consultants and which are approved by the Interim Chief Financial Officer.
	Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.
	The Company used a Monte Carlo model to value Level 3 financial liabilities at inception and on subsequent valuation dates, except that the conversion feature of the convertible notes immediately prior to conversion was valued at intrinsic value. This simulation incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk free rates, as well as, volatility. The Company also used a binomial simulation and Black-Scholes economic model as supplemental valuation tools in order to validate the reasonableness of the results of the Monte Carlo simulation when measuring the Financing Warrant and the Consulting Warrant.
	A significant increase in the volatility or a significant increase in the Company’s stock price, in isolation, would result in a significantly higher fair value measurement. Changes in the values of the derivative liabilities were recorded in Change in Fair Value of Derivative Liabilities within Other Expense (Income) on the Company’s Statements of Operations.
	As of December 31, 2014, there were no transfers in or out of level 3 from other levels in the fair value hierarchy.
	In accordance with the provisions of ASC 815, the Company presented the conversion feature and warrant liabilities at fair value on its balance sheet, with the corresponding changes in fair value recorded in the Company’s statement of operations for the applicable reporting periods.
	Management determined that the results of its valuations are reasonable.
	Recent Accounting Pronouncements
In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers" (Topic 606), which supersedes the revenue recognition requirements in ASC Topic 605, "Revenue Recognition," and most industry-specific guidance. This ASU is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. The amendments in the ASU must be applied using one of two retrospective methods and are effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. The Company will evaluate the effects, if any, that adoption of this guidance will have on its financial statements.
In June 2014, the FASB issued ASU No. 2014-10, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation." This ASU removes the definition of a development stage entity from the ASC, thereby removing the financial reporting distinction between development stage entities and other reporting entities from GAAP. In addition, the ASU eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of operations, cash flows, and stockholders’ equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. This ASU is effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. Early adoption is permitted. The Company elected to adopt this ASU effective with the Quarterly Report on Form 10-Q filed on August 14, 2014 and its adoption resulted in the removal of previously required development stage disclosures.
The FASB has issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. This ASU requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. The Company elected to adopt this ASU effective with the Quarterly Report on Form 10-Q filed on November 10, 2014 and its adoption did not have a material effect on its financial statements.
In August 2014, FASB issued ASU No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. This standard is intended to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. Under U.S. GAAP, financial statements are prepared under the presumption that the reporting organization will continue to operate as a going concern, except in limited circumstances. Financial reporting under this presumption is commonly referred to as the going concern basis of accounting.
The going concern basis of accounting is critical to financial reporting because it establishes the fundamental basis for measuring and classifying assets and liabilities. Currently, U.S. GAAP lacks guidance about management’s responsibility to evaluate whether there is substantial doubt about the organization’s ability to continue as a going concern or to provide related footnote disclosures. This ASU provides guidance to an organization’s management, with principles and definitions that are intended to reduce diversity in the timing and content of disclosures that are commonly provided by organizations today in the financial statement footnotes. The amendments are effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early application is permitted for annual or interim reporting periods for which the financial statements have not previously been issued. The adoption of this standard is not expected to have a material impact on the Company’s financial position and results of operations.
Management’s Evaluation of Subsequent Events
The Company evaluates events that have occurred after the balance sheet date of December 31, 2014, through the date which the financial statements are issued. Based upon the review, other than as disclosed in Note 12, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Property_and_Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 4 – Property and Equipment
	Property and equipment are as follows:
		As of
		December 31, 2014		December 31, 2013
	Computer software	$	459,861	$	114,876
	Computer hardware		725,739		36,240
	Furniture and fixtures		342,452		28,458
	Leasehold improvements		343,734		14,755
			1,871,786		194,329
	Less – accumulated depreciation		-356,487		-4,717
	Total property and equipment, net	$	1,515,299	$	189,612
	Total depreciation and amortization expense of the Company’s property and equipment was $371,189 and $4,717, for the years ended ended December 31, 2014 and 2013, respectively, reflected within general and administrative expense.

Accrued_Expenses_and_Other_Cur

Accrued Expenses and Other Current Liabilities	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]	Note 5 – Accrued Expenses and Other Current Liabilities
	Accrued expenses consist of the following:
		As of
		December 31, 2014		December 31, 2013
	Accrued interest payable	$	-	$	207,945
	Accrued compensation		425,824		19,894
	Other accrued expenses		366,525		15,784
	Total	$	792,349	$	243,623

Private_Placement

Private Placement	12 Months Ended
	Dec. 31, 2014
Private Placement [Abstract]
Private Placement [Text Block]	Note 6 – Private Placement
	Senior Secured Convertible Notes
	On May 16, 2013, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with accredited investors (the “Investors”), pursuant to which the Company sold an aggregate of $5,500,009 principal amount of senior secured convertible notes (the “Convertible Notes”). In connection with the sale of the Convertible Notes (the “Bridge Financing”), the Company entered into a registration rights agreement (the “Registration Rights Agreement”) and a security agreement (the “Security Agreement”) with the Investors. The closing of the Bridge Financing was completed on May 16, 2013. The Convertible Notes bore interest at 6% per annum and would have matured on August 16, 2014.
	In connection with the funding of the IPO, on April 2, 2014, the principal and interest due under the Convertible Notes of $5,500,009 and $290,219, were converted into 1,833,336 and 96,792 shares, respectively, of common stock. The security agreement terminated on April 2, 2014, upon the conversion of the Convertible Notes.
	Accounting for the Senior Secured Convertible Notes
	Pursuant to the terms of the Convertible Notes, the conversion price was subject to adjustment in the event of an IPO, other financing and upon certain other events. The embedded conversion feature was not clearly and closely related to the host instrument and was bifurcated from the host Convertible Notes as a derivative, principally because the instrument’s variable exercise price terms would not qualify as being indexed to the Company’s own common stock. Accordingly, through April 1, 2014, this conversion feature instrument was classified as a derivative liability.  Derivative liabilities are initially recorded at fair value and are then re-valued at each reporting date, with changes in fair value recognized in earnings during the reporting period.
	The Company calculated the fair value of the embedded conversion feature of the Convertible Notes at April 2, 2014 at the conversion features’ fair value, with the observable assumptions as provided in the table below.
		As of
		April 2, 2014
	Stock price on valuation date	$	13.88
	Conversion price	$	3
	Fair value	$	26,790,177
	The amortization of debt discount related to the Convertible Notes was $964,851 and $705,289, respectively, for the years ended December 31, 2014 and 2013.  During the years ended December 31, 2014 and 2013, the Company recorded an increase of $21,217,177 and $197,000, respectively, in the fair value of the derivative liability for the conversion feature of the Convertible Notes, which was recorded as a change in the fair value of derivative liabilities within the statement of operations. On April 2, 2014, upon the consummation of the IPO, the Convertible Notes and Accrued Interest were converted to 1,833,336 and 96,792 shares, respectively, of the Company’s common stock. This conversion was accounted for as an extinguishment. Accordingly, on April 2, 2014, the Company recorded a gain of $2,084,368 upon the extinguishment of the Convertible Notes, accrued interest, and the related derivative liability. Thereupon, the 1,930,128 shares of common stock were issued and were recorded at their aggregate fair value of $26,790,177.
	Placement Agent Agreement
	On January 23, 2013, the Company entered into an agreement (the “Placement Agent Agreement”) with MDB Capital Group, Inc. (“MDB”), pursuant to which the Company appointed MDB to act as the Company’s placement agent in connection with the sale of the Company’s securities (“Offering or Offerings”). Specifically, MDB was the placement agent in connection with the sale of its Convertible Notes.
	In connection with the sale of the Convertible Notes, the Company paid MDB a cash fee of $538,393 and sold to MDB for $1,000 in cash, a warrant issued on May 16, 2013 (the “Financing Warrant”) to purchase shares of the Company’s common stock. The Financing Warrant was fully vested upon issuance, has a term of five years and may not be exercised until six months after the consummation of a qualifying firm commitment underwritten initial public offering. Pursuant to the terms of the Financing Warrant, the aggregate exercise price is fixed at $550,000, with the per share exercise price being $3.60 based upon 120% of the conversion price of $3.00 of the Convertible Notes upon the consummation of the IPO. As of December 31, 2014, the Financing Warrant was exercisable into 152,778 shares of the Company’s common stock, assuming an exercise price of $3.60 per share (or 120% of the Convertible Notes conversion price of $3.00 per share).
	As originally executed and through June 24, 2014, in the event of a non-liquid exit transaction, as defined in the Financing Warrant agreement, the holder of the Financing Warrant could have put the Financing Warrant back to the Company for a cash settlement at a fair value amount that would be determined by appraisal and agreed to by both parties (the “Financing Warrant Put”). On June 25, 2014, the Financing Warrant was modified to remove the Financing Warrant put feature.
	MDB shall have certain registration rights with respect to the common stock issued upon exercise of the Financing Warrant, including a onetime demand registration right with respect to such common stock.
	Consulting Agreement
	On January 23, 2013, the Company entered into a consulting agreement with MDB (the “Consulting Agreement”), pursuant to which MDB agreed to provide financial, strategic and intellectual property advisory services. The Consulting Agreement had an initial term of 180 days, and was renewed automatically upon the expiration of its initial term, after which it will continue in effect until it is terminated by either party with 30 days written notice to the other party. On July 11, 2014, the Company provided notice to MDB of its termination of the Consulting Agreement.
	As consideration for services provided under the Consulting Agreement prior to May 16, 2013, the Company sold to MDB for $1,500 in cash, a warrant (the “Consulting Warrant”) for the purchase of an aggregate of 278,228 shares of the Company’s common stock. The Consulting Warrant was fully vested upon issuance, has a term of five years, an exercise price of $0.04 per share and may not be exercised until six months after the consummation of the IPO. The Consulting Warrant may be exercised on a cashless basis. As originally executed and through June 24, 2014, in the event of a non-liquid exit transaction, as defined in the Consulting Warrant, the holder of the Consulting Warrant could have put the Consulting Warrant back to the Company for a cash settlement at a fair value amount that would be determined by appraisal and agreed to by both parties (the “Consulting Warrant Put”). On June 25, 2014, the Consulting Warrant was modified to remove the Consulting Warrant put feature.
	MDB shall have certain registration rights with respect to the common stock issued upon exercise of the Consulting Warrant, including a onetime demand registration right with respect to such common stock.
	Accounting for the Financing Warrant and the Consulting Warrant
	The Company determined that due to their cash settlement features, as originally issued, both the Financing Warrant and the Consulting Warrant qualified as derivative instruments.  Accordingly upon issuance, these instruments were classified as derivative liabilities.  Derivative liabilities are initially recorded at fair value and are then re-valued at each reporting date, with changes in fair value recognized in earnings during the reporting period. Effective on June 25, 2014, upon the removal of the cash settlement put features within the Financing Warrant and the Consulting Warrant, (as discussed above), each of the Consulting Warrant and the Financing Warrant no longer qualified as derivative instruments. Accordingly, on June 25, 2014, after first recording a mark-to-market adjustment to fair value, the aggregate fair value of $5,752,000 for both warrants was reclassified to additional paid in capital.
	The Company calculated the fair value of the Financing Warrant and the Consulting Warrant using a Monte Carlo simulation, with the observable assumptions as provided in the table below. The significant unobservable inputs used in the fair value measurement of the reporting entity’s Financing Warrant and the Consulting Warrant are expected stock prices, levels of trading and liquidity of the Company’s common stock. Significant increases in the expected stock prices and expected liquidity would result in a significantly higher fair value measurement. Significant increases in either the probability or severity of default of the host instrument would result in a significantly lower fair value measurement.
	Provided below are the principal assumptions used in the measurement of the fair values of the Financing Warrant and the Consulting Warrant as of June 24, 2014 and December 31, 2013.
		As of June 24, 2014						As of December 31, 2013
		Financing			Consulting			Financing			Consulting
		Warrant			Warrant			Warrant			Warrant
	Stock price on valuation date	$	14.69		$	14.69		$	1.68		$	1.68
	Exercise price	$	3.6		$	0.04		$	2.49		$	0.04
	Term (years)		3.89			3.89			4.38			4.38
	Expected volatility		60	%		60	%		60	%		60	%
	Dividend yield		0	%		0	%		0	%		0	%
	Weighted average risk-free interest rate		1.33	%		1.33	%		1.75	%		1.75	%
	Number of warrants		152,778			278,228			220,905			278,228
	Number of trials		20,000			20,000			20,000			20,000
	Aggregate fair value	$	1,733,000		$	4,019,000		$	175,000		$	529,000
	The initial fair value of the Financing Warrant was $186,500 and was accounted for as derivative issuance expense and along with the other derivative issuance expenses (see below), was expensed upon the issuance of the Convertible Notes. The initial fair value of the Consulting Warrant was $537,500, and was expensed immediately as a consulting fee and was recorded within general and administrative expenses in the statement of operations for the year ended December 31, 2013. During the years ended December 31, 2014 and 2013, the Company recorded an increase of $5,048,000 and decrease of $20,000, respectively, in the fair values of the derivative liability of the Financing Warrant and the Consulting Warrant, which was recorded as a change in the fair value of derivative liabilities within the statement of operations.
	Patent Assignment
	On May 16, 2013, the Company entered into a patent assignment and Security Agreement with the Investors, in order to grant a continuing security interest in the patents included as collateral pledged in connection with the Convertible Notes. The security interest in the Company’s patents terminated on April 2, 2014, in connection with the conversion of the Convertible Notes.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 7 – Commitments and Contingencies
	Investor Relations Agreement
	Effective January 13, 2014, the Company entered into an agreement with a vendor (“IR Firm”) to provide investor relations services to the Company. Pursuant to the agreement, in addition to monthly cash compensation of $8,000 per month, on March 27, 2014 the Company issued to the IR firm a consulting warrant (“IR Consulting Warrant”) for the purchase of 36,000 shares of common stock. The IR Consulting Warrant has a strike price of $7.80, representing 130% of the IPO price. The IR Consulting Warrant had an initial catch up vesting equivalent to 3,000 shares per month of service, partial months to be prorated on a thirty (30) day basis, from the effective date of this agreement until March 27, 2014. Thereafter, the IR Consulting Warrant vested at a rate of 3,000 shares per month of service. In addition, the Company agreed to issue to the IR Firm incentive warrants (“IR Incentive Warrants”) to purchase 5,000 shares of common stock with a strike price of $7.80 in the event of and upon each qualified investor, institutional or brokerage firm purchasing at least $250,000 in value of the Company’s common shares at the IPO price or greater in the open market on or after the 46th day following March 27, 2014. All IR Incentive Warrants granted during a six month period will collectively vest at each six month anniversary. Both the IR Consulting Warrant and IR Incentive Warrants will have an expiration date four (4) years from the grant date. The shares underlying both the IR Consulting Warrant and the IR Incentive Warrants will either be registered at the next available opportunity or the warrants will include a cashless exercise provision.
	As of December 31, 2014, 34,800 shares under the IR Consulting Warrant were vested.
	As of December 31, 2014 a total of 15,000 IR Incentive Warrants were deemed to have vested. Accordingly as of December 31, 2014, the Company recorded the accrued value of the IR Incentive Warrant of approximately $92,000 in general and administrative expenses, since the Company does not record stock-based compensation until the associated warrant is approved by the Board of Directors and issued. On February 26, 2015, the Board of Directors approved the issuance of a warrant to purchase 15,000 shares of the Company’s common stock.
	For the year ended December 31, 2014, the Company incurred stock-based compensation expense of $263,972 in connection with the IR Consulting warrant, which was included in general and administrative expense.
	Operating Leases
	On October 4, 2013, the Company executed a lease expiring on June 4, 2014 for 3,562 square feet of office space in Pleasanton, California from an affiliate of Greg Brewer, one of the Company’s former directors, with a base rent of $6,055 per month. The lease was amended and extended to September 30, 2014 with a base monthly rent of $8,548 for the period June 5, 2014 through September 30, 2014.
	On September 10, 2014, the Company entered into a Lease Agreement (the “Lease”) with Balzer Family Investments, L.P. (the “Landlord”) related to space located at Northpointe Business Center, 3590 North First Street, San Jose, California. The initial term of the lease is 60 months, with initial monthly base rent of $36,720. On October 1, 2014, the Company relocated its headquarters to this new location.  The Company issued to the Landlord 41,563 shares of the Company’s common stock valued at $500,000, of which $400,000 will be applied to reduce the Company’s monthly base rent obligation by $6,732 per month and of which $100,000 was for certain tenant improvements. The Company recorded $400,000 as prepaid rent on its balance sheet, which will be amortized over the term of the lease and recorded $100,000 as leasehold improvements.
	The future minimum lease payments are as follows:
	For the Year Ended December 31,	Amount
	2015		362,555
	2016		373,432
	2017		384,635
	2018		396,174
	2019		303,766
	Thereafter		0
	Total	$	1,820,562

Stockholders_Equity_Deficit

Stockholders' Equity (Deficit)	12 Months Ended
	Dec. 31, 2014
Stockholders Equity Note [Abstract]
Stockholders Equity Note Disclosure [Text Block]	Note 8 – Stockholders’ Equity (Deficit)
	Authorized Capital
	The holders of the Company’s common stock are entitled to one vote per share. Holders of common stock are entitled to receive ratably such dividends, if any, as may be declared by the board of directors out of legally available funds. Upon the liquidation, dissolution or winding up of the Company, holders of common stock are entitled to share ratably in all assets of the Company that are legally available for distribution.
	Sale of Common Stock
	The Company entered into a stock purchase agreement dated March 7, 2014, under which a strategic investor (‘Strategic Investor”) agreed to purchase 210,527 shares of our common stock $0.0001 par value for gross proceeds of $1,000,000. On April 4, 2014, the Company issued 210,527 shares of common stock upon the receipt of the proceeds of $1,000,000 ($300,000 received on March 27, 2014, $700,000 received on April 4, 2014). In connection with this sale, the Company paid a commission of $100,000 to MDB. The shares issued are subject to a one year lock-up and a one year voting control agreement.
	Amendment to Certificate of Incorporation
	On March 26, 2014, the Company’s board of directors and stockholders approved the Second Amended and Restated Certificate of Incorporation which increased the authorized shares to 60,000,000 of which 10,000,000 shares are designated as preferred stock. In addition, a special meeting of stockholders can only be called by the Chairman, Chief Executive Officer, President or the majority of the board of directors and shall be limited to matters relating to the purpose or purposes stated in the notice of meeting. Any actions required, as a result of a special stockholder meeting, can only be taken upon the vote of the stockholders and not by written consent. The stockholders empowered the board of directors at any time prior to the effectiveness of the filing of this Second Amendment and Restated Certificate to abandon the proposed amendment.
	Initial Public Offering
	The registration statement for the Company’s IPO was declared effective on March 27, 2014. On April 2, 2014, the Company consummated the Public Offering of 4,600,000 shares of common stock (including 600,000 shares issued pursuant to the over-allotment option granted to the underwriter) at $6.00 per share and received from the underwriter net proceeds of $25,214,596 (net of underwriter’s discount of $2,208,000 and underwriter offering expenses of $177,404). The Company incurred additional offering expenses of $430,745, yielding net proceeds from the IPO of $24,783,851.
	IPO Underwriter Warrant
	Simultaneous with the funding of the IPO, the Company issued to the underwriter a warrant to purchase 460,000 shares of common stock (“IPO Underwriter Warrant”) at an exercise price of $7.50 per share with an expiration date of April 2, 2024. The IPO underwriter warrant was recorded net of the proceeds from the IPO.
	Secondary Offering
	The registration statement for the Company’s Secondary Offering was declared effective on December 15, 2014. On December 15, 2014, the Company consummated the Public Offering of 3,285,714 shares of common stock at $7.00 per share and received from the underwriters’ net proceeds of $21,239,998 (net of underwriters’ discount of $1,610,000 and underwriters’ offering expenses of $150,000). The Company incurred additional offering expenses of $246,239, yielding net proceeds from the IPO of $20,993,759.

Stock_Based_Compensation

Stock Based Compensation	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 9 – Stock Based Compensation
	Equity Incentive Plans
	2013 Equity Incentive Plan
	In December 2013 the Company’s board and stockholders approved the “2013 Equity Incentive Plan”, providing for the issuance of equity based instruments covering up to an initial total of 1,042,167 shares of common stock. Effective on March 27, 2014, the aggregate total shares which may be issued under the 2013 Equity Incentive Plan were increased to 2,335,967, as described below.
	Effective on March 10, 2014, the Company’s board of directors and stockholders approved the First Amendment to the 2013 Equity Incentive Plan which provided for an increase in the aggregate number of shares of common stock that may be issued pursuant to the Plan to equal 18% of the total number of shares of common stock outstanding immediately following the completion of the IPO (assuming for this purpose the issuance of all shares issuable under the Company’s equity plans, the conversion into common stock of all outstanding securities that are convertible by their terms into common stock and the exercise of all options and warrants exercisable for shares of common stock and including shares and warrants issued to the underwriters for such IPO upon exercise of its over-allotment options).
	As of December 31, 2014, 531,661 shares of common stock remain eligible to be issued through equity based instruments under the 2013 Equity Incentive Plan.
	2014 Non-Employee Equity Compensation Plan
	On March 6, 2014, the Company’s board of directors and stockholders approved the 2014 Non-Employee Equity Compensation Plan for the issuance of equity based instruments covering up to 250,000 shares of common stock to directors and other non-employees.
	As of December 31, 2014, 211,184 shares of common stock remains eligible to be issued through equity based instruments under the 2014 Non-Employee Equity Compensation Plan.
	Option Valuation
	The Company has computed the fair value of options granted using the Black-Scholes option pricing model. Option forfeitures are estimated at the time of valuation and reduce expense ratably over the vesting period. This estimate will be adjusted periodically based on the extent to which actual option forfeitures differ, or are expected to differ, from the previous estimate, when it is material. The expected term used for options issued to non-employees is the contractual life and the expected term used for options issued to employees is the estimated period of time that options granted are expected to be outstanding. The Company utilizes the “simplified” method to develop an estimate of the expected term of “plain vanilla” employee option grants. Since the Company’s stock has not been publicly traded for a sufficiently long period of time, the Company is utilizing an expected volatility figure based on a review of the historical volatilities, over a period of time, equivalent to the expected life of the instrument being valued, of similarly positioned public companies within its industry. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued.
	Stock Options
	On December 12, 2013, Mr. Rizzone, the Company’s Chief Executive Officer, was granted an option under the 2013 Equity Incentive Plan to purchase 275,689 shares of the Company’s common stock, at a price of $1.68 per share, with a term of ten years and which vests 1/48 for each completed month of service and for purposes of vesting only, the first completed month of service was determined to be October 2013. The option has a grant date fair value of $258,373 utilizing the Black-Scholes option pricing model.
	On January 7, 2014, the Company’s board of directors granted to various employees and consultants from the 2013 Equity Incentive Plan stock options to purchase an aggregate of 537,845 shares of the Company’s common stock at an exercise price of $2.49 per share and having a term of ten years. Included in these grants were 57,644 options to Michael Leabman, Chief Technical Officer, pursuant to his employment contract, 80,201 options to George Holmes, Vice President of Sales and Marketing, and 319,799 options to other employees and consultants. The option awards granted to Mr. Leabman vested 3/48ths on the date of grant, and will vest 1/48th monthly over the following 45 months. The option award granted to Mr. Holmes vested 25% on October 1, 2014 and then continues to vest 1/48th of the initial award monthly for the subsequent 36 months. Option awards granted to all other employees and consultants cliff vest 25% of the award on the later of the first anniversary of the date they started working for the Company or October 1, 2014 and then will vest 1/48th of the initial award monthly for the following 36 months. The options had an aggregate grant date fair value of $762,699 utilizing the Black-Scholes option pricing model.
	On February 27, 2014, the Company granted non-qualified stock options for the purchase of 25,979 shares of the Company’s common stock each to two new independent directors of the Company as part of their compensation for serving on the Company’s board of directors. The options have an exercise price of $3.63 per share and have a term of ten years. The Options vest 25% on March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014. The options had an aggregate grant date fair value of $100,000 utilizing the Black-Scholes option pricing model.
	On March 15, 2014 and March 20, 2014, the Company granted non-qualified stock options from the 2014 Non-Employee Equity Compensation Plan for the purchase of an aggregate of 34,781 shares of the Company’s common stock to two new independent directors of the Company as part of their compensation for serving on the Company’s board of directors. The options have a weighted average exercise price of $5.45 per share and have a term of ten years. The Options vest 25% on March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014. The options had an aggregate grant date fair value of $100,000 utilizing the Black-Scholes option pricing model.
	On March 15, 2014, the Company’s board of directors granted to a single employee an option under the 2013 Equity Incentive Plan to purchase 80,201 shares of the Company’s common stock at an exercise price of $4.99.  The option award granted to the employee has a ten year term and cliff vests 25% of the award on the anniversary of the employee’s date of hire and then will vest 1/48th of the initial award monthly during the following 36 months. The option had a grant date fair value of $229,365 utilizing the Black-Scholes option pricing model.
	On March 26, 2014, the Company’s board of directors granted to Mr. Rizzone, the Company’s Chief Executive Officer, an option under the 2013 Equity Incentive Plan to purchase 496,546 shares of the Company’s common stock, at a price of $6.00 per share, with a term of ten years and which vests 6/48 of the award on the grant date and 1/48 of the award on the last day of each of the subsequent 42 months. The option had a grant date fair value of $1,667,784 utilizing the Black-Scholes option pricing model.
	On March 26, 2014, the Company’s board of directors granted to Michael Leabman, Chief Technical Officer, pursuant to his employment contract a stock option under the 2013 Equity Incentive Plan to purchase 251,474 shares of the Company’s common stock at an exercise price of $6.00.  The option award granted to Mr. Leabman has a ten year term and vests 6/48th of the award on the grant date and 1/48th of the award on the last day of each of the subsequent 42 months. The option had a grant date fair value of $844,643 utilizing the Black-Scholes option pricing model.
	On March 26, 2014, the Company’s board of directors granted to Mr. Holmes a stock option under the 2013 Equity Incentive Plan to purchase 89,672 shares of the Company’s common stock at an exercise price of $6.00.  The option award granted to the consultant has a ten year term and vested 25% of the award on September 30, 2014 and continues to vest 1/48th of the award on the last day of each of the subsequent 36 months. The option had a grant date fair value of $303,869 utilizing the Black-Scholes option pricing model.
	The Company estimated the fair value of stock options awarded during the year ended December 31, 2014 using the Black-Scholes option pricing model. The fair values of stock options granted were estimated using the following assumptions:
			Option Grants
			Awarded During the
			Year Ended
			December 31, 2014
	Stock price			$2.49 to $6.00
	Dividend yield			0%
	Expected volatility			60%
	Risk-free interest rate			1.30% to 2.03%
	Expected life			3.75 to 6.25 years
	As of December 31, 2014, the unamortized value of options held by employees was $2,611,490. As of December 31, 2014, the unamortized portion will be expensed over a weighted average period of 2.68 years.
	Stock Option Award Activity
	The following is a summary of the Company’s stock option activity during the year ended December 31, 2014:
			Number of			Weighted			Weighted			Weighted		Intrinsic
			Options			Average			Average			Average		Value
						Exercise			Grant Date			Remaining
						Price			Fair Value			Life In
												Years
	Outstanding, January 1, 2014			275,689		$	1.68		$	-			-	$	-
	Granted			1,542,477			4.63			2.6			-		-
	Exercised			-			-			-			-		-
	Forfeited			-211,091			2.49			1.57			-		-
	Outstanding December 31, 2014			1,607,075		$	4.41		$	2.46			9	$	10,532,322
	Exercisable, January 1, 2014			17,231		$	1.68		$	-			-	$	-
	Vested			533,067			4.41			-			-		-
	Exercised			-			-			-			-		-
	Forfeited			-			-			-			-		-
	Exercisable, December 31, 2014			550,298		$	4.33		$	2.41			9.1	$	3,649,854
	The following table presents information related to stock options outstanding and exercisable at December 31, 2014:
	Options Outstanding						Options Exercisable
	Exercise Price			Outstanding			Weighted Average			Exercisable Number of
				Number of			Remaining Life In			Options
				Options			Years
	$	1.68			275,689			8.9			86,153
		2.49			326,754			9			115,627
		3.63			51,958			9.2			51,958
		4.99			99,214			9.2			19,013
		6			853,460			9.2			277,547
					1,607,075			9.1			550,298
	Restricted Stock Units (“RSUs”)
	On June 3, 2014, the compensation committee of the board of directors of the Company granted to a member of the Company’s advisory board, an RSU award under which the holder has the right to receive 4,035 shares of common stock. The award was granted under the 2014 Non-Employee Equity Compensation Plan. The RSU had a grant date fair value of $49,590 based upon the fair value of the Company’s common stock on the date of grant. This RSU had 1,513 shares vested as of December 31, 2014 and vests 504 shares on each of the next five succeeding three month anniversaries of the grant date.
	On July 14, 2014, the compensation committee of the board of directors granted to George Holmes an RSU under which the holder has the right to receive 44,836 shares of the Company’s common stock. The award was granted under the 2013 Equity Incentive Plan. The RSU had a grant date fair value of $593,180 based upon the fair value of the Company’s common stock on the date of grant. The award granted to Mr. Holmes vests 25% on March 28, 2015 and then 25% annually until fully vested. March 28, 2018. Pursuant to the terms of the award, the shares not vested terminate upon separation from the Company.
	On July 14, 2014, the compensation committee of the board of directors granted to various employees and consultants, RSUs under which the holders have the right to receive 228,500 shares of the Company’s common stock. These awards were granted under the 2013 Equity Incentive Plan and the RSU’s had an aggregate grant date fair value of $3,023,055 based upon the fair value of the Company’s common stock on the date of grant. The awards granted vest 25% on March 28, 2015 and then 25% annually until fully vested on March 28, 2018. Pursuant to the terms of the awards, the shares not vested terminate upon separation from the Company.
	On August 14, 2014, the compensation committee of the board of directors granted to various employees and consultants, RSUs under which the holders have the right to receive 86,823 shares of the Company’s common stock. These awards were granted under the 2013 Equity Incentive Plan and the RSU’s had an aggregate grant date fair value of $981,100 based upon the fair value of the Company’s common stock on the date of grant. The awards granted vest over four years beginning on the first anniversary of the employee’s date of hire. Pursuant to the terms of the awards, the shares not vested terminate upon separation from the Company.
In addition, on August 14, 2014, the compensation committee of the board of directors granted two inducement RSU awards to Cesar Johnston, the Company’s Senior Vice President of Engineering. Under the first award, Mr. Johnston has the right to receive 100,000 shares of the Company’s common stock and this award vests over four years beginning on the first anniversary of his employment start date of July 14, 2014. In addition, Mr. Johnston was granted 20,000 performance based RSU awards. On February 26, 2015, the compensation committee of the board of director determined that Mr. Johnston had successfully met all conditions provided for in the performance based RSU award. The RSU’s had an aggregate grant date fair value of $1,356,000 based upon the fair value of the Company’s common stock on the date of grant. The awards granted vest over four years beginning on the first anniversary of the employee’s date of hire. Pursuant to the terms of the awards, the shares not vested terminate upon separation from the Company.
On November 13, 2014, the compensation committee of the board of directors granted inducement RSU awards to various employees and consultants, under which the holders have the right to receive 261,686 shares of the Company’s common stock. These inducement awards were not granted under a plan. These RSUs had an aggregate grant date fair value of $2,266,201 based upon the fair value of the Company’s common stock on the date of grant. Pursuant to the terms of the awards, the shares are not vested upon separation from the Company.
In addition, on November 13, 2014, the compensation committee of the board of directors granted to various employees and consultants, RSUs under which the holders have the right to receive 5,100 shares of the Company’s common stock. These awards were granted under the 2013 Equity Incentive Plan as an incentive reward for being a named inventor on one or more of the Company’s patent applications, and the RSUs had an aggregate fair value of $44,166 based upon the fair value of the Company’s common stock on the date of grant. Pursuant to the terms of the awards, the shares vested immediately upon grant and common stock delivery is one year from the related patent application date.
On December 24, 2014, the compensation committee of the board of directors granted inducement RSU awards to various employees and consultants, under which the holders have the right to receive 77,856 shares of the Company’s common stock. These inducement awards were not granted under a plan. These RSUs had an aggregate grant date fair value of $620,512 based upon the fair value of the Company’s common stock on the date of grant. The awards granted vest over four years beginning on the first anniversary of the employee’s date of hire. Pursuant to the terms of the awards, the shares not vested terminate upon separation from the Company.
On December 24, 2014, the compensation committee of the board of directors granted an RSU award to a consultant, under which the holder has the right to receive 5,000 shares of the Company’s common stock. This award was granted under the 2013 Equity Incentive Plan and had a grant date fair value of $39,850 based upon the fair value of the Company’s common stock on the date of grant. The awards granted vest over four years beginning on the first anniversary of the employee’s date of hire. Pursuant to the terms of the awards, the shares not vested terminate upon separation from the Company.
The Company accounts for RSUs granted to consultants using the accounting guidance included in ASC 505-50 “Equity-Based Payments to Non-Employees” (“ASC 505-50”). In accordance with ASC 505-50, the Company estimates the fair value of the unvested portion of the RSU award each reporting period using the closing price of the Company’s common stock.
At December 31, 2014, the unamortized value of the RSUs was $6,734,336. The unamortized amount will be expensed over a weighted average period of 3.47 years. A summary of the activity related to RSUs for the year ended December 31, 2014 is presented below:
		Total			Weighted			Total Grant
					Average Grant			Date Fair Value
					Date Fair
					Value
Nonvested at January 1, 2014			-		$	-		$	-
RSU Granted			837,672			10.75			9,006,874
RSUs vested			-6,349			9.94			-63,116
RSUs forfeited			-104,044			12.57			-1,308,067
Nonvested at December 31, 2014			727,279			10.5		$	7,635,691
Vested at December 31, 2014			6,349		$	9.94		$	63,116
Stock-Based Compensation Expense
The following tables summarize total stock based compensation costs recognized for the year ended December 31, 2014 and 2013.
		Year Ended December 31,
		2014			2013
Stock options		$	1,333,943		$	16,148
RSUs			900,063			-
IR warrant			263,972			-
Shares issued to consultant for services rendered			50,000			-
Total		$	2,547,978		$	16,148
The total amount of stock-based compensation was reflected within the statements of operations as:
		Year Ended December 31,
		2014			2013
Research and development		$	924,702		$	-
General and administrative			1,040,038			16,148
Sales and marketing			583,238			-
Total		$	2,547,978		$	16,148

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Note 10 - Income Taxes
	As of December 31, 2014 and 2013, the Company’s deferred tax assets (liabilities) consisted of the effects of temporary differences attributable to the following:
		December 31,
		2014			2013
	Deferred tax assets (liabilities):
	Tax credit and net operating loss carryovers	$	3,191,795		$	900,830
	Property and equipment		-20,282			-
	Research and development costs		5,820,399			845,900
	Start-up and organizational costs		1,443			1,554
	Stock-based compensation		448,893			647
	Other accruals		188,439			90,680
	Total gross deferred tax assets		9,630,687			1,839,611
	Less: valuation allowance		-9,630,687			-1,839,611
	Deferred tax assets, net	$	-		$	-
	The change in the Company’s valuation allowance is as follows:
		2014			2013
	January 1,	$	1,839,611		$	8,472
	Increase in valuation allowance		7,791,076			1,831,139
	December 31,	$	9,630,687		$	1,839,611
	The Company has a net operating loss carryover of approximately $5,815,000 and a research and development tax credit carryover of approximately $878,000 that expire beginning in 2032. The ultimate realization of the net operating loss is dependent upon future taxable income, if any, of the Company and may be limited in any one period by alternative minimum tax rules. Although management believes that the Company may have sufficient future taxable income to absorb the net operating loss carryovers and research and development tax credit carryovers before the expiration of the carryover period, there may be circumstances beyond the Company’s control that limit such utilization. Accordingly, management has determined that a full valuation allowance of the deferred tax asset is appropriate at December 31, 2014 and 2013.
	Internal Revenue Code Section 382 imposes limitations on the use of net operating loss carryovers when the stock ownership of one or more 5% shareholders (shareholders owning 5% or more of the Company’s outstanding capital stock) has increased on a cumulative basis by more than 50 percentage points. Management cannot control the ownership changes occurring as a result of public trading of the Company’s Common Stock. Accordingly, there is a risk of an ownership change beyond the control of the Company that could trigger a limitation of the use of the loss carryover. As of December 31, 2014, the Company has not completed an analysis whether an ownership change occurred under Section 382, which, if it did occur, could substantially limit its ability in the future to utilize its net operating loss and other tax carryforwards.
		For the Year			For the Year
		Ended			Ended
		December 31,			December 31,
		2014			2013
	Tax benefit at federal statutory rate		-34	%		-34	%
	State income taxes		-5.8			-5.8
	Permanent difference:
	Stock-based compensation		1.1			0.1
	Derivative instrument issuance - financing warrant		-			1.3
	Change in fair value of derivative liability		22.9			1.3
	General and administrative expense - consulting warrant		-			3.9
	Amortization of debt discount		0.8			-
	Gain on debt extinguishment		-1.8			-
	Other		0.6			-
	Federal research and development tax credit		-0.9			-
	Increase in valuation allowance		17.1			33.2
	Effective income tax rate		0	%		0	%

Related_Parties

Related Parties	12 Months Ended
	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 11 – Related Parties
	On October 4, 2013, the Company executed a lease expiring on June 4, 2014 for 3,562 square feet of office space in Pleasanton, California from an affiliate of Greg Brewer, one of the Company’s former directors, with a base rent of $6,055 per month. The lease was amended and extended to September 30, 2014 with a base monthly rent of $8,548 for the period June 5, 2014 through September 30, 2014.
	On July 14, 2014, the Company’s Board of Directors appointed Howard Yeaton as the Company’s Interim Chief Financial Officer. Howard Yeaton is the Managing Principal of Financial Consulting Strategies LLC (“FCS”). During the year ended December 31, 2014, the Company has paid to FCS $68,413 in connection with Howard Yeaton’s services as Interim Chief Financial Officer and $126,153 for other financial advisory and accounting services provided by FCS.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 12 – Subsequent Events
	Development and Licensing Agreement
	Effective January 28, 2015, the Company signed a development and licensing agreement with a consumer electronics company to embed WattUp wire-free charging receiver technology in various products including, but not limited to mobile consumer electronics and related accessories. During the development phase and through customer shipment of their first product, Energous will afford this customer an exclusive time to market advantage in the licensed product categories.
	This development and licensing agreement contains both invention and development milestones that the Company will need to achieve during the next two years. Pursuant to the Agreement, the Company will receive development payments based upon its achievement of milestones, as provided for in the Agreement, including the receipt of an initial payment of $500,000 earned upon the signing of the Agreement.
	Grants of RSUs
	On January 22, 2015, the compensation committee of the board of directors granted to various employees and consultants, RSUs under which the holders have the right to receive 54,500 shares of the Company’s common stock. The awards granted were vested on the date of grant.
	On February 26, 2015, the compensation committee of the board of directors granted to two employees RSUs under which the holders have the right to receive 6,800 shares of the Company’s common stock. The awards granted were vested on the date of grant.
	On February 26, 2015, the compensation committee of the board of directors granted to Mr. Rizzone, the Company’s Chief Executive Officer, RSUs under which Mr. Rizzone has the right to receive 246,226 shares of the Company’s common stock. The awards were granted under the 2013 Equity Incentive Plan and vest over four years beginning on the first anniversary of the date of grant.
	Issuance of Common Stock
	On February 4, 2015, the Company entered into an advisory agreement with Insight Capital Consultants Corporation (“Insight”), pursuant to which, on February 26, 2015, the Company issued to Insight 15,000 shares of common stock.
	Lease Agreement
	On February 26, 2015, the Company entered into a sub-lease agreement for additional space in the San Jose area. The agreement has a term which expires on June 30, 2019 at an initial monthly rent of $6,109 per month.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation
	The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”).
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements as well as the reported expenses during the reporting periods.
	The Company’s significant estimates and assumptions include the valuation of the Company’s common stock, the valuation of stock-based compensation instruments and the valuation of derivative financial instruments, the amortization of deferred financing costs, the useful lives of long-lived assets, and income tax expense. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Although the Company believes that its estimates and assumptions are reasonable, they are based upon information available at the time the estimates and assumptions were made. Actual results could differ from those estimates.
Research and Development Expense, Policy [Policy Text Block]	Research and Development
	Research and development expenses are charged to operations as incurred. For internally developed patents, all patent application costs are expensed as incurred as research and development expense. Patent application costs, generally legal costs, are expensed as research and development costs until such time as the future economic benefits of such patents become more certain. The Company incurred research and development costs of $12,511,647 and $2,109,890 for the years ended December 31, 2014 and 2013, respectively.
Income Tax, Policy [Policy Text Block]	Income Taxes
	Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. As of December 31, 2014, no liability for unrecognized tax benefits was required to be reported. The guidance also discusses the classification of related interest and penalties on income taxes. The Company’s policy is to record interest and penalties on uncertain tax positions as a component of income tax expense. No interest or penalties were recorded during the years ended December 31, 2014 and 2013.
Earnings Per Share, Policy [Policy Text Block]	Net Income (Loss) Per Common Share
	Basic net income (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and warrants (using the treasury stock method), the vesting of restricted stock units (“RSUs”), the exercise and/or conversion of the Company’s convertible notes (using the if-converted method). The computation of diluted loss per share excludes potentially dilutive securities of 3,261,360 and 3,525,904 for the years ended December 31, 2014 and 2013, respectively, because their inclusion would be antidilutive.
	Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net income (loss) per share because the effect of their inclusion would have been anti-dilutive.
		For the Year Ended
		December 31,
		2014		2013
	Convertible Notes – principal		-		2,650,858
	Convertible Notes – accrued interest		-		100,224
	Consulting Warrant to purchase common stock		278,228		278,228
	Financing Warrant to purchase common stock		152,778		220,905
	IPO Warrants  to purchase common stock		460,000		-
	IR Consulting Warrant		36,000		-
	Options to purchase common stock		1,607,075		275,689
	RSUs		727,279		-
	Total potentially dilutive securities		3,261,360		3,525,904
Fair Value Measurement, Policy [Policy Text Block]	Fair Value Measurements
	The carrying amounts of cash and cash equivalents, accounts payable and accrued expenses, approximate fair value due to the short-term nature of these instruments. Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:
	Level 1	Quoted prices in active markets for identical assets or liabilities.
	Level 2	Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.
	Level 3	Significant unobservable inputs that cannot be corroborated by market data.
	The assets or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. The following table provides a summary of the liabilities that are measured at fair value on a recurring basis.
						Quoted
				Quoted Prices		Prices for
				in Active		Similar
				Markets for		Assets or
				Identical		Liabilities in		Significant
				Assets or		Active		Unobservable
				Liabilities		Markets		Inputs
		Total		(Level 1)		(Level 2)		(Level 3)
	Derivative Liabilities:
	December 31, 2013:
	Conversion Feature	$	5,573,000	$	-	$	-	$	5,573,000
	Financing Warrant		175,000		-		-		175,000
	Consulting Warrant		529,000		-		-		529,000
	Total	$	6,277,000	$	-	$	-	$	6,277,000
	As of December 31, 2014, the Company no longer had financial instruments which were derivative liabilities.
	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:
		For the Year Ended
		December 31, 2014
	Beginning balance	$	6,277,000
	Change in fair value of conversion feature and warrants		26,265,177
	Extinguishment of derivative liability upon conversion of Convertible Notes		-26,790,177
	Extinguishment of derivative liability upon modification of Financing Warrant		-1,733,000
	Extinguishment of derivative liability upon modification of Consulting Warrant		-4,019,000
	Ending balance	$	-
	The conversion feature of the Convertible Notes immediately prior to conversion was measured at fair value using a Monte Carlo simulation (which also represented the intrinsic value of the conversion feature) and was classified within Level 3 of the valuation hierarchy. The warrant liabilities for the Financing Warrant and the Consulting Warrant, immediately prior to modification were measured at fair value using a Monte Carlo simulation and were classified within Level 3 of the valuation hierarchy. The significant assumptions and valuation methods that the Company used to determine fair value and the change in fair value of the Company’s derivative financial instruments are discussed in Note 6 – Private Placement.
	Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the derivative liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s Interim Chief Financial Officer determined its valuation policies and procedures. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s Interim Chief Financial Officer with support from the Company’s consultants and which are approved by the Interim Chief Financial Officer.
	Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.
	The Company used a Monte Carlo model to value Level 3 financial liabilities at inception and on subsequent valuation dates, except that the conversion feature of the convertible notes immediately prior to conversion was valued at intrinsic value. This simulation incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk free rates, as well as, volatility. The Company also used a binomial simulation and Black-Scholes economic model as supplemental valuation tools in order to validate the reasonableness of the results of the Monte Carlo simulation when measuring the Financing Warrant and the Consulting Warrant.
	A significant increase in the volatility or a significant increase in the Company’s stock price, in isolation, would result in a significantly higher fair value measurement. Changes in the values of the derivative liabilities were recorded in Change in Fair Value of Derivative Liabilities within Other Expense (Income) on the Company’s Statements of Operations.
	As of December 31, 2014, there were no transfers in or out of level 3 from other levels in the fair value hierarchy.
	In accordance with the provisions of ASC 815, the Company presented the conversion feature and warrant liabilities at fair value on its balance sheet, with the corresponding changes in fair value recorded in the Company’s statement of operations for the applicable reporting periods.
	Management determined that the results of its valuations are reasonable.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements
	In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers" (Topic 606), which supersedes the revenue recognition requirements in ASC Topic 605, "Revenue Recognition," and most industry-specific guidance. This ASU is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. The amendments in the ASU must be applied using one of two retrospective methods and are effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. The Company will evaluate the effects, if any, that adoption of this guidance will have on its financial statements.
	In June 2014, the FASB issued ASU No. 2014-10, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation." This ASU removes the definition of a development stage entity from the ASC, thereby removing the financial reporting distinction between development stage entities and other reporting entities from GAAP. In addition, the ASU eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of operations, cash flows, and stockholders’ equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. This ASU is effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. Early adoption is permitted. The Company elected to adopt this ASU effective with the Quarterly Report on Form 10-Q filed on August 14, 2014 and its adoption resulted in the removal of previously required development stage disclosures.
	The FASB has issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. This ASU requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. The Company elected to adopt this ASU effective with the Quarterly Report on Form 10-Q filed on November 10, 2014 and its adoption did not have a material effect on its financial statements.
	In August 2014, FASB issued ASU No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. This standard is intended to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. Under U.S. GAAP, financial statements are prepared under the presumption that the reporting organization will continue to operate as a going concern, except in limited circumstances. Financial reporting under this presumption is commonly referred to as the going concern basis of accounting.
	The going concern basis of accounting is critical to financial reporting because it establishes the fundamental basis for measuring and classifying assets and liabilities. Currently, U.S. GAAP lacks guidance about management’s responsibility to evaluate whether there is substantial doubt about the organization’s ability to continue as a going concern or to provide related footnote disclosures. This ASU provides guidance to an organization’s management, with principles and definitions that are intended to reduce diversity in the timing and content of disclosures that are commonly provided by organizations today in the financial statement footnotes. The amendments are effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early application is permitted for annual or interim reporting periods for which the financial statements have not previously been issued. The adoption of this standard is not expected to have a material impact on the Company’s financial position and results of operations.
Subsequent Events, Policy [Policy Text Block]	Management’s Evaluation of Subsequent Events
	The Company evaluates events that have occurred after the balance sheet date of December 31, 2014, through the date which the financial statements are issued. Based upon the review, other than as disclosed in Note 12, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net income (loss) per share because the effect of their inclusion would have been anti-dilutive.
		For the Year Ended
		December 31,
		2014		2013
	Convertible Notes – principal		-		2,650,858
	Convertible Notes – accrued interest		-		100,224
	Consulting Warrant to purchase common stock		278,228		278,228
	Financing Warrant to purchase common stock		152,778		220,905
	IPO Warrants  to purchase common stock		460,000		-
	IR Consulting Warrant		36,000		-
	Options to purchase common stock		1,607,075		275,689
	RSUs		727,279		-
	Total potentially dilutive securities		3,261,360		3,525,904
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	The following table provides a summary of the liabilities that are measured at fair value on a recurring basis.
						Quoted
				Quoted Prices		Prices for
				in Active		Similar
				Markets for		Assets or
				Identical		Liabilities in		Significant
				Assets or		Active		Unobservable
				Liabilities		Markets		Inputs
		Total		(Level 1)		(Level 2)		(Level 3)
	Derivative Liabilities:
	December 31, 2013:
	Conversion Feature	$	5,573,000	$	-	$	-	$	5,573,000
	Financing Warrant		175,000		-		-		175,000
	Consulting Warrant		529,000		-		-		529,000
	Total	$	6,277,000	$	-	$	-	$	6,277,000
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:
		For the Year Ended
		December 31, 2014
	Beginning balance	$	6,277,000
	Change in fair value of conversion feature and warrants		26,265,177
	Extinguishment of derivative liability upon conversion of Convertible Notes		-26,790,177
	Extinguishment of derivative liability upon modification of Financing Warrant		-1,733,000
	Extinguishment of derivative liability upon modification of Consulting Warrant		-4,019,000
	Ending balance	$	-

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Property and equipment are as follows:
		As of
		December 31, 2014		December 31, 2013
	Computer software	$	459,861	$	114,876
	Computer hardware		725,739		36,240
	Furniture and fixtures		342,452		28,458
	Leasehold improvements		343,734		14,755
			1,871,786		194,329
	Less – accumulated depreciation		-356,487		-4,717
	Total property and equipment, net	$	1,515,299	$	189,612

Accrued_Expenses_and_Other_Cur1

Accrued Expenses and Other Current Liabilities (Tables)	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities [Table Text Block]	Accrued expenses consist of the following:
		As of
		December 31, 2014		December 31, 2013
	Accrued interest payable	$	-	$	207,945
	Accrued compensation		425,824		19,894
	Other accrued expenses		366,525		15,784
	Total	$	792,349	$	243,623

Private_Placement_Tables

Private Placement (Tables)	12 Months Ended
	Dec. 31, 2014
Private Placement [Line Items]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	The Company calculated the fair value of the embedded conversion feature of the Convertible Notes at April 2, 2014 at the conversion features’ fair value, with the observable assumptions as provided in the table below.
		As of
		April 2, 2014
	Stock price on valuation date	$	13.88
	Conversion price	$	3
	Fair value	$	26,790,177
Financing And Consulting Warrant [Member]
Private Placement [Line Items]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	Provided below are the principal assumptions used in the measurement of the fair values of the Financing Warrant and the Consulting Warrant as of June 24, 2014 and December 31, 2013.
		As of June 24, 2014						As of December 31, 2013
		Financing			Consulting			Financing			Consulting
		Warrant			Warrant			Warrant			Warrant
	Stock price on valuation date	$	14.69		$	14.69		$	1.68		$	1.68
	Exercise price	$	3.6		$	0.04		$	2.49		$	0.04
	Term (years)		3.89			3.89			4.38			4.38
	Expected volatility		60	%		60	%		60	%		60	%
	Dividend yield		0	%		0	%		0	%		0	%
	Weighted average risk-free interest rate		1.33	%		1.33	%		1.75	%		1.75	%
	Number of warrants		152,778			278,228			220,905			278,228
	Number of trials		20,000			20,000			20,000			20,000
	Aggregate fair value	$	1,733,000		$	4,019,000		$	175,000		$	529,000

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2014
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	The future minimum lease payments are as follows:
	For the Year Ended December 31,	Amount
	2015		362,555
	2016		373,432
	2017		384,635
	2018		396,174
	2019		303,766
	Thereafter		0
	Total	$	1,820,562

Stock_Based_Compensation_Table

Stock Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	The Company estimated the fair value of stock options awarded during the year ended December 31, 2014 using the Black-Scholes option pricing model. The fair values of stock options granted were estimated using the following assumptions:
			Option Grants
			Awarded During the
			Year Ended
			December 31, 2014
	Stock price			$2.49 to $6.00
	Dividend yield			0%
	Expected volatility			60%
	Risk-free interest rate			1.30% to 2.03%
	Expected life			3.75 to 6.25 years
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	The following is a summary of the Company’s stock option activity during the year ended December 31, 2014:
			Number of			Weighted			Weighted			Weighted		Intrinsic
			Options			Average			Average			Average		Value
						Exercise			Grant Date			Remaining
						Price			Fair Value			Life In
												Years
	Outstanding, January 1, 2014			275,689		$	1.68		$	-			-	$	-
	Granted			1,542,477			4.63			2.6			-		-
	Exercised			-			-			-			-		-
	Forfeited			-211,091			2.49			1.57			-		-
	Outstanding December 31, 2014			1,607,075		$	4.41		$	2.46			9	$	10,532,322
	Exercisable, January 1, 2014			17,231		$	1.68		$	-			-	$	-
	Vested			533,067			4.41			-			-		-
	Exercised			-			-			-			-		-
	Forfeited			-			-			-			-		-
	Exercisable, December 31, 2014			550,298		$	4.33		$	2.41			9.1	$	3,649,854
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	The following table presents information related to stock options outstanding and exercisable at December 31, 2014:
	Options Outstanding						Options Exercisable
	Exercise Price			Outstanding			Weighted Average			Exercisable Number of
				Number of			Remaining Life In			Options
				Options			Years
	$	1.68			275,689			8.9			86,153
		2.49			326,754			9			115,627
		3.63			51,958			9.2			51,958
		4.99			99,214			9.2			19,013
		6			853,460			9.2			277,547
					1,607,075			9.1			550,298
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	A summary of the activity related to RSUs for the year ended December 31, 2014 is presented below:
			Total			Weighted			Total Grant
						Average Grant			Date Fair Value
						Date Fair
						Value
	Nonvested at January 1, 2014			-		$	-		$	-
	RSU Granted			837,672			10.75			9,006,874
	RSUs vested			-6,349			9.94			-63,116
	RSUs forfeited			-104,044			12.57			-1,308,067
	Nonvested at December 31, 2014			727,279			10.5		$	7,635,691
	Vested at December 31, 2014			6,349		$	9.94		$	63,116
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	The following tables summarize total stock based compensation costs recognized for the year ended December 31, 2014 and 2013.
			Year Ended December 31,
			2014			2013
	Stock options		$	1,333,943		$	16,148
	RSUs			900,063			-
	IR warrant			263,972			-
	Shares issued to consultant for services rendered			50,000			-
	Total		$	2,547,978		$	16,148
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]	The total amount of stock-based compensation was reflected within the statements of operations as:
			Year Ended December 31,
			2014			2013
	Research and development		$	924,702		$	-
	General and administrative			1,040,038			16,148
	Sales and marketing			583,238			-
	Total		$	2,547,978		$	16,148

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	As of December 31, 2014 and 2013, the Company’s deferred tax assets (liabilities) consisted of the effects of temporary differences attributable to the following:
		December 31,
		2014			2013
	Deferred tax assets (liabilities):
	Tax credit and net operating loss carryovers	$	3,191,795		$	900,830
	Property and equipment		-20,282			-
	Research and development costs		5,820,399			845,900
	Start-up and organizational costs		1,443			1,554
	Stock-based compensation		448,893			647
	Other accruals		188,439			90,680
	Total gross deferred tax assets		9,630,687			1,839,611
	Less: valuation allowance		-9,630,687			-1,839,611
	Deferred tax assets, net	$	-		$	-
Summary of Valuation Allowance [Table Text Block]	The change in the Company’s valuation allowance is as follows:
		2014			2013
	January 1,	$	1,839,611		$	8,472
	Increase in valuation allowance		7,791,076			1,831,139
	December 31,	$	9,630,687		$	1,839,611
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]		For the Year			For the Year
		Ended			Ended
		December 31,			December 31,
		2014			2013
	Tax benefit at federal statutory rate		-34	%		-34	%
	State income taxes		-5.8			-5.8
	Permanent difference:
	Stock-based compensation		1.1			0.1
	Derivative instrument issuance - financing warrant		-			1.3
	Change in fair value of derivative liability		22.9			1.3
	General and administrative expense - consulting warrant		-			3.9
	Amortization of debt discount		0.8			-
	Gain on debt extinguishment		-1.8			-
	Other		0.6			-
	Federal research and development tax credit		-0.9			-
	Increase in valuation allowance		17.1			33.2
	Effective income tax rate		0	%		0	%

Business_Organization_Nature_o1

Business Organization, Nature of Operations (Details Textual)	10 Months Ended
	Dec. 31, 2014
Business Organization And Nature Of Operations [Line Items]
Stockholders Equity, Reverse Stock Split	1-for-3.99 reverse split

Liquidity_and_Management_Plans1

Liquidity and Management Plans (Details Textual) (USD $)	1 Months Ended	3 Months Ended	12 Months Ended		1 Months Ended
	Apr. 30, 2014	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Dec. 31, 2012
Liquidity And Management Plans [Line Items]
Net income (numerator for basic and diluted earnings per share)			($45,603,110)	($5,521,081)
Cash and Cash Equivalents, at Carrying Value, Total		31,494,592	31,494,592	1,953,780		994
Proceeds from Issuance of Common Stock	900,000	21,000,000	0	200,681
Debt Conversion, Converted Instrument, Shares Issued			1,833,336	96,792
Stock Issued During Period Shares Upon Conversion Of Debt Instrument Interest			96,792
Proceeds from Other Equity	700,000		900,000	0
Payments for Commissions	100,000		100,000
Common Stock [Member]
Liquidity And Management Plans [Line Items]
Net income (numerator for basic and diluted earnings per share)			0	0
Stock Issued During Period, Shares, New Issues			4,600,000
Stock Issued During Period, Shares, Issued for Services	210,527		210,527		210,527
Proceeds from Other Equity	700,000				300,000
Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration			41,563
Stock Issued During Period, Shares, Share-based Compensation, Gross			5,353
Stock Issued During Period, Shares, Other			3,285,714
IPO [Member]
Liquidity And Management Plans [Line Items]
Stock Issued During Period, Shares, New Issues	4,600,000
Proceeds from Issuance of Common Stock	$24,800,000

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	3,261,360	3,525,904
Convertible Notes Principal [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	0	2,650,858
Convertible Notes Accrued Interest [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	0	100,224
Consulting Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	278,228	278,228
Financing Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	152,778	220,905
IPO Warrants [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	460,000	0
IR Consulting Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	36,000	0
Stock Option [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	1,607,075	275,689
Restricted Stock Units (RSUs) [Member]
Summary Of Significant Accounting Policies [Line Items]
Potentially dilutive securities	727,279	0

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Jun. 24, 2014
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities	$0	$6,277,000
Fair Value, Inputs, Level 1 [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		0
Fair Value, Inputs, Level 2 [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		0
Fair Value, Inputs, Level 3 [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		6,277,000
Convertible Notes Payable [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		5,573,000
Convertible Notes Payable [Member] | Fair Value, Inputs, Level 1 [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		0
Convertible Notes Payable [Member] | Fair Value, Inputs, Level 2 [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		0
Convertible Notes Payable [Member] | Fair Value, Inputs, Level 3 [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		5,573,000
Financing Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		175,000	1,733,000
Financing Warrant [Member] | Fair Value, Inputs, Level 1 [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		0
Financing Warrant [Member] | Fair Value, Inputs, Level 2 [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		0
Financing Warrant [Member] | Fair Value, Inputs, Level 3 [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		175,000
Consulting Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		529,000	4,019,000
Consulting Warrant [Member] | Fair Value, Inputs, Level 1 [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		0
Consulting Warrant [Member] | Fair Value, Inputs, Level 2 [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		0
Consulting Warrant [Member] | Fair Value, Inputs, Level 3 [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Liabilities		$529,000

Summary_of_Significant_Account5

Summary of Significant Accounting Policies (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies [Line Items]
Beginning balance		$6,277,000
Ending balance	0	6,277,000
Convertible Notes Payable [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Fair Value Of Derivative Net	-26,790,177
Convertible Debt Securities [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Fair Value Of Derivative Net	26,265,177
Financing Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Fair Value Of Derivative Net	-1,733,000
Consulting Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative Fair Value Of Derivative Net	($4,019,000)

Summary_of_Significant_Account6

Summary of Significant Accounting Policies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies [Line Items]
Research and Development Expense, Total	$12,511,647	$2,109,890
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,261,360	3,525,904

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	$1,871,786	$194,329
Less - Accumulated depreciation	-356,487	-4,717
Total property and equipment, net	1,515,299	189,612
Computer Software [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	459,861	114,876
Computer Hardware [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	725,739	36,240
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	342,452	28,458
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	$343,734	$14,755

Property_and_Equipment_Details1

Property and Equipment (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Depreciation, Depletion and Amortization, Total	$371,189	$4,717

Accrued_Expenses_and_Other_Cur2

Accrued Expenses and Other Current Liabilities (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Schedule of Accrued Liabilities [Line Items]
Accrued Liabilities, Current	$792,349	$243,623
Accrued interest payable [Member]
Schedule of Accrued Liabilities [Line Items]
Accrued Liabilities, Current	0	207,945
Accrued compensation [Member]
Schedule of Accrued Liabilities [Line Items]
Accrued Liabilities, Current	425,824	19,894
Other accrued expenses [Member]
Schedule of Accrued Liabilities [Line Items]
Accrued Liabilities, Current	$366,525	$15,784

Private_Placement_Details

Private Placement (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Apr. 02, 2014
Private Placement [Line Items]
Fair value	$0	$6,277,000
Convertible Notes Payable [Member]
Private Placement [Line Items]
Stock price on valuation date			$13.88
Conversion price	$3		$3
Fair value			$26,790,177

Private_Placement_Details_1

Private Placement (Details 1) (USD $)	6 Months Ended	12 Months Ended
	Jun. 24, 2014	Dec. 31, 2013	Dec. 31, 2014
Private Placement [Line Items]
Aggregate fair value		$6,277,000	$0
Consulting Warrant [Member]
Private Placement [Line Items]
Stock price on valuation date	$14.69	$1.68
Exercise price	$0.04	$0.04
Term (years)	3 years 10 months 20 days	4 years 4 months 17 days
Expected volatility	60.00%	60.00%
Dividend yield	0.00%	0.00%
Weighted average risk-free interest rate	1.33%	1.75%
Number of warrants	278,228	278,228
Number of trials	20,000	20,000
Aggregate fair value	4,019,000	529,000
Financing Warrant [Member]
Private Placement [Line Items]
Stock price on valuation date	$14.69	$1.68
Exercise price	$3.60	$2.49	$3.60
Term (years)	3 years 10 months 20 days	4 years 4 months 17 days
Expected volatility	60.00%	60.00%
Dividend yield	0.00%	0.00%
Weighted average risk-free interest rate	1.33%	1.75%
Number of warrants	152,778	220,905
Number of trials	20,000	20,000
Aggregate fair value	$1,733,000	$175,000

Private_Placement_Details_Text

Private Placement (Details Textual) (USD $)	12 Months Ended		1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Apr. 30, 2014	Jun. 24, 2014	Aug. 16, 2014	Apr. 02, 2014	16-May-13
Private Placement [Line Items]
Securities Purchase Agreement Initiation Date	16-May-13
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,261,360	3,525,904
Amortization of Debt Discount (Premium)	$964,851	$705,289
Fair Value Adjustment of Warrants	0	724,000
Debt Conversion, Converted Instrument, Amount	26,790,177	0
Debt Conversion, Converted Instrument, Shares Issued	1,833,336	96,792
Debt Instrument, Convertible, Beneficial Conversion Feature	21,217,177	197,000
Gains (Losses) on Extinguishment of Debt	2,084,368	0
Stock Issued During Period, Value, Conversion of Convertible Securities	26,790,177
Adjustments to Additional Paid in Capital, Other	5,752,000	0
Common Stock [Member]
Private Placement [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities	1,930,128
Stock Issued During Period, Value, Conversion of Convertible Securities	19
Adjustments to Additional Paid in Capital, Other	0
Financing Warrant [Member]
Private Placement [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	152,778	220,905
Payments for Fees	538,393
Sale Of Warrants In Cash	1,000
Warrants Aggregate Exercise Price	550,000
Percentage Exercise Price Of Warrants Determined Based On Conversion Price Of Convertible Notes	120.00%
Investment Warrants, Exercise Price	$3.60
Percentage Of Warrants Exercise Based On Convertible Notes Conversion Price	120.00%
Fair Value Adjustment of Warrants	186,500
Fair Value Assumptions, Exercise Price	$3.60	$2.49		$3.60
Consulting Warrant [Member]
Private Placement [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	278,228	278,228
Sale Of Warrants In Cash	1,500
Investment Warrants, Exercise Price	$0.04
Warrants Issued To Purchase Common Stock, Shares	278,228
Fair Value Adjustment of Warrants	537,500
Fair Value Assumptions, Exercise Price		$0.04		$0.04
Financing And Consulting Warrant [Member]
Private Placement [Line Items]
Increase (Decrease) in Derivative Liabilities	5,048,000	20,000
InterestPayable [Member]
Private Placement [Line Items]
Debt Conversion, Converted Instrument, Amount			290,219
Debt Conversion, Converted Instrument, Shares Issued			96,792
Convertible Notes Payable [Member]
Private Placement [Line Items]
Debt Instrument, Face Amount							5,500,009
Debt Instrument, Interest Rate, Stated Percentage					6.00%
Debt Instrument, Maturity Date	16-Aug-14
Debt Instrument, Convertible, Conversion Price	$3					$3
Debt Conversion, Converted Instrument, Amount			$5,500,009
Debt Conversion, Converted Instrument, Shares Issued			1,833,336

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	Dec. 31, 2014
Commitments and Contingencies [Line Items]
2015	$362,555
2016	373,432
2017	384,635
2018	396,174
2019	303,766
Thereafter	0
Total	$1,820,562

Commitments_and_Contingencies_2

Commitments and Contingencies (Details Textual) (USD $)	12 Months Ended		1 Months Ended	4 Months Ended	1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Oct. 31, 2014	Sep. 30, 2014	Sep. 30, 2014	Feb. 26, 2015	Oct. 04, 2013
							sqft
Commitments and Contingencies [Line Items]
Investor Relations Agreement, Initiation Date	13-Jan-14
Stock based compensation expense	$2,547,978	$16,148
Cash Compensation For Services Received Per Month 1	8,000
Lease Expiration Date		4-Jun-14
Extended Lease Expiration Date	30-Sep-14
Development Stage Entities, Stock Issued, Value, Issued for Noncash Consideration	500,000	0
Payments for Tenant Improvements	100,000
Payments for Rent	400,000
General and Administrative Expense, Total	5,059,703	1,204,896
Proceeds from Issuance of Warrants	1,000	0
Office Building [Member]
Commitments and Contingencies [Line Items]
Area of Land							3,562
Operating Leases, Rent Expense			6,055	8,548
Balzer Family Investments, L.P [Member]
Commitments and Contingencies [Line Items]
Operating Leases, Rent Expense					36,720
Operating Leases Expiration Period					60 months
Operating Leases, Rent Expense, Net					6,732
Common Stock [Member]
Commitments and Contingencies [Line Items]
Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration	41,563
IR Consulting Warrant [Member]
Commitments and Contingencies [Line Items]
Warrants Issued To Purchase Common Stock, Shares	36,000
Investment Warrants, Exercise Price	$7.80
Warrants Exercise Price, Representing IPO Price Percentage	130.00%
Warrants Vesting, Each Month Of Service	3,000
Warrants Vesting Thereafter, Each Month Of Service	3,000
Warrant Vested During Period, Shares	34,800
Stock based compensation expense	263,972
Proceeds from Issuance of Warrants						15,000
IR Incentive Warrant [Member]
Commitments and Contingencies [Line Items]
Warrants Issued To Purchase Common Stock, Shares	5,000
Investment Warrants, Exercise Price	$7.80
Warrant Vested During Period, Shares	15,000
Terms Of Incentive Warrant Market Maker	250,000
General and Administrative Expense, Total	$92,000
IR Consulting And Incentive Warrant [Member]
Commitments and Contingencies [Line Items]
Warrants Term	4 years

Stockholders_Equity_Deficit_De

Stockholders' Equity (Deficit) (Details Textual) (USD $)	1 Months Ended	12 Months Ended		1 Months Ended	0 Months Ended
	Apr. 30, 2014	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Dec. 15, 2014	Mar. 26, 2014	Mar. 07, 2014	Apr. 02, 2014
Class of Stock [Line Items]
Common Stock, Shares Authorized		50,000,000	40,000,000			60,000,000
Preferred Stock, Shares Authorized		10,000,000	0			10,000,000
Proceeds from Issuance Initial Public Offering		$24,872,170	$0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		3,261,360	3,525,904
Sale of Stock, Price Per Share							$0.00
Proceeds from Other Equity	700,000	900,000	0
Payments for Commissions	100,000	100,000
Payments of Stock Issuance Costs		2,816,149
Common Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues		4,600,000
Proceeds from Issuance or Sale of Equity	1,000,000			1,000,000
Stock Issued During Period, Shares, Issued for Services	210,527	210,527		210,527
Proceeds from Other Equity	700,000			300,000
IPO [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues	4,600,000
Shares Issued, Price Per Share								$6
Proceeds from Issuance or Sale of Equity		25,214,596
Payments for Underwriting Expense		177,404
Proceeds from Issuance Initial Public Offering		24,783,851			20,993,759
Common Stock, Discount on Shares								2,208,000
Payments of Stock Issuance Costs		430,745
Over-Allotment Option [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues		600,000
Secondary Offering [Member]
Class of Stock [Line Items]
Sale of Stock, Price Per Share					$7
Payments of Stock Issuance Costs					246,239
Stock Issued During Period, Value, Other					3,285,714
Secondary Offering [Member] | Underwriter [Member]
Class of Stock [Line Items]
Proceeds from Issuance or Sale of Equity					21,239,998
Payments for Underwriting Expense					150,000
Common Stock, Discount on Shares					$1,610,000
Initial Public Offering Warrant [Member]
Class of Stock [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		460,000
Investment Warrants, Exercise Price		$7.50

Stock_Based_Compensation_Detai

Stock Based Compensation (Details) (USD $)	12 Months Ended
	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.00%
Expected volatility	60.00%
Risk-free interest rate, Minimum	1.30%
Risk-free interest rate, Maximum	2.03%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock price	2.49
Expected life	3 years 9 months
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock price	6
Expected life	6 years 3 months

Stock_Based_Compensation_Detai1

Stock Based Compensation (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options, Outstanding	275,689
Number of Options, Granted	1,542,477
Number of Options, Exercised	0
Number of Options, Forfeited	-211,091
Number of Options, Outstanding	1,607,075
Number of Options, Exercisable	17,231
Number of Options, Vested	533,067
Number of Options, Exercisable	550,298
Weighted Average Exercise Price, Outstanding	$1.68
Weighted Average Exercise Price, Granted	$4.63
Weighted Average Exercise Price, Exercised	$0
Weighted Average Exercise Price, Forfeited	$2.49
Weighted Average Exercise Price, Outstanding	$4.41
Weighted Average Exercise Price, Exercisable	$1.68
Weighted Average Exercise Price, Vested	$4.41
Weighted Average Exercise Price, Exercisable	$4.33
Weighted Average Grant Date Fair Value, Outstanding	$0
Weighted Average Grant Date Fair Value, Granted	$2.60
Weighted Average Grant Date Fair Value, Exercised	$0
Weighted Average Grant Date Fair Value, Forfeited	$1.57
Weighted Average Grant Date Fair Value, Outstanding	$2.46
Weighted Average Grant Date Fair Value, Exercisable	$2.41
Weighted Average Remaining Life In Years, Outstanding	9 years
Weighted Average Remaining Life In Years, Exercisable	9 years 1 month 6 days
Intrinsic Value, Outstanding	$0
Intrinsic Value, Exercised	0
Intrinsic Value, Outstanding	10,532,322
Intrinsic Value, Exercisable	0
Intrinsic Value, Exercisable	$3,649,854

Stock_Based_Compensation_Detai2

Stock Based Compensation (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price	$4.41	$1.68
Number of Options, Outstanding	1,607,075	275,689
Weighted Average Remaining Life In Years	9 years 1 month 6 days
Number of Options, Exercisable	550,298	17,231
Stock Option One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price	$1.68
Number of Options, Outstanding	275,689
Weighted Average Remaining Life In Years	8 years 10 months 24 days
Number of Options, Exercisable	86,153
Stock Option Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price	$2.49
Number of Options, Outstanding	326,754
Weighted Average Remaining Life In Years	9 years
Number of Options, Exercisable	115,627
Stock Option Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price	$3.63
Number of Options, Outstanding	51,958
Weighted Average Remaining Life In Years	9 years 2 months 12 days
Number of Options, Exercisable	51,958
Stock Option Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price	$4.99
Number of Options, Outstanding	99,214
Weighted Average Remaining Life In Years	9 years 2 months 12 days
Number of Options, Exercisable	19,013
Stock Option Five [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price	$6
Number of Options, Outstanding	853,460
Weighted Average Remaining Life In Years	9 years 2 months 12 days
Number of Options, Exercisable	277,547

Stock_Based_Compensation_Detai3

Stock Based Compensation (Details 3) (USD $)	12 Months Ended
	Dec. 31, 2014
Share based Compensation Arrangement By Share based Payment Award Options Non vested Grant Date Fair Value
Vested at December 31, 2014	6,349
Weighted Average Grant Date Fair Value, Vested at December 31, 2014	$9.94
Total Grant Date Fair Value, Vested at December 31, 2014	$63,116
Restricted Stock Units (RSUs) [Member]
Share based Compensation Arrangement By Share based Payment Award Options Non vested Grant Date Fair Value
Nonvested at January 1, 2014	0
RSU Granted	837,672
RSUs vested	-6,349
RSUs forfeited	-104,044
Nonvested at December 31, 2014	727,279
Weighted Average Grant Date Fair Value, Nonvested at January 1, 2014	$0
Weighted Average Grant Date Fair Value, RSU Granted	$10.75
Weighted Average Grant Date Fair Value, RSUs vested	$9.94
Weighted Average Grant Date Fair Value, RSUs forfeited	$12.57
Weighted Average Grant Date Fair Value, Nonvested at December 31, 2014	$10.50
Total Grant Date Fair Value, Nonvested at January 1, 2014	0
Total Grant Date Fair Value, RSU Granted	9,006,874
Total Grant Date Fair Value, RSUs vested	-63,116
Total Grant Date Fair Value, RSUs forfeited	-1,308,067
Total Grant Date Fair Value, Nonvested at December 31, 2014	$7,635,691

Stock_Based_Compensation_Detai4

Stock Based Compensation (Details 4) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based Compensation, Total	$2,547,978	$16,148
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	900,063	0
IR Consulting Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	263,972	0
Consultant For Services Rendered [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	50,000	0
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	$1,333,943	$16,148

Stock_Based_Compensation_Detai5

Stock Based Compensation (Details 5) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based Compensation, Total	$2,547,978	$16,148
Research and Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	924,702	0
General and Administrative Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	1,040,038	16,148
Sales and Marketing Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	$583,238	$0

Stock_Based_Compensation_Detai6

Stock Based Compensation (Details Textual) (USD $)

12 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

12 Months Ended

Dec. 31, 2014

Dec. 31, 2014

Nov. 30, 2014

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Aug. 31, 2014

Jul. 31, 2014

Dec. 31, 2013

Dec. 24, 2014

Nov. 13, 2014

Aug. 14, 2014

Mar. 15, 2014

Jul. 14, 2014

Mar. 26, 2014

Dec. 12, 2013

Mar. 06, 2014

Jan. 07, 2014

Feb. 27, 2014

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1,542,477

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$4.63

Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition

3 years 5 months 19 days

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

837,672

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

-6,349

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options

$6,734,336

6,734,336

6,734,336

Employees And Consultants [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

77,856

261,686

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

620,512

2,266,201

Two New Independent Directors [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

25.00%

25.00%

25.00%

25.00%

Mr. Cesar Johnston | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

100,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

1,356,000

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

4 years

Equity Incentive Plan 2013 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

1,042,167

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

80,201

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$4.99

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vests 25% of the award on the anniversary of the employees date of hire and then will vest 1/48th of the initial award monthly during the following 36 months

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

229,365

Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease)

2,335,967

Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms

18%

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures

531,661

Equity Incentive Plan 2013 [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

5,100

228,500

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

44,166

981,100

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date

28-Mar-18

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

4 years

4 years

Equity Incentive Plan 2013 [Member] | Employees And Consultants [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

86,823

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

3,023,055

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

25.00%

Equity Incentive Plan 2013 [Member] | Mr.Michael Leabman [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

251,474

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$6

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vests 6/48th of the award on the grant date and 1/48th of the award on the last day of each of the subsequent 42 months

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

844,643

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Equity Incentive Plan 2013 [Member] | Mr. George Holmes [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

89,672

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$6

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Equity Incentive Plan 2013 [Member] | Mr. George Holmes [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

44,836

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

593,180

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

25.00%

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

4 years

Equity Incentive Plan 2013 [Member] | Mr. Rizzone [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

496,546

275,689

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$6

$1.68

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vests 6/48 of the award on the grant date and 1/48 of the award on the last day of each of the subsequent 42 months

vests 1/48 for each completed month of service and for purposes of vesting only, the first completed month

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

1,667,784

258,373

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

10 years

Equity Incentive Plan 2013 [Member] | Consultant [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vested 25% of the award on September 30, 2014 and continues to vest 1/48th of the award on the last day of each of the subsequent 36 months

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

303,869

Equity Incentive Plan 2013 [Member] | Consultant [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

5,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

39,850

Non-Employee Equity Compensation Plan 2014 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

250,000

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

25.00%

25.00%

25.00%

25.00%

Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures

211,184

Non-Employee Equity Compensation Plan 2014 [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award

vests 504 shares on each of the next five succeeding three month anniversaries of the grant date

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

4,035

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

49,590

49,590

49,590

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

1,513

Non-Employee Equity Compensation Plan 2014 [Member] | Two New Independent Directors [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

34,781

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$5.45

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vest 25% on March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

100,000

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Stock Plan 2013 [Member] | Employees And Consultants [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

537,845

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$2.49

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Stock Plan 2013 [Member] | Mr.Michael Leabman [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

57,644

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

3/48ths on the date of grant, and will vest 1/48th monthly over the following 45 months

Stock Plan 2013 [Member] | Mr. George Holmes [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

80,201

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vested 25% on October 1, 2014 and then continues to vest 1/48th of the initial award monthly for the subsequent 36 months

Stock Plan 2013 [Member] | Other Employees And Consultants [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

319,799

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vest 25% of the award on the later of the first anniversary of the date they started working for the Company or October 1, 2014 and then will vest 1/48thof the initial award monthly for the following 36 months

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

762,699

Stock Plan 2013 [Member] | Two New Independent Directors [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

25,979

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$3.63

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

vest 25% on March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014

Share Based Compensation Arrangement by Share Based Payment Award, Options, Grant in Period, Weighted Average Grant Date Fair Value

100,000

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Employee Stock Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options

$2,611,490

2,611,490

2,611,490

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition

2 years 8 months 5 days

Performance Shares [Member] | Mr. Cesar Johnston | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

20,000

Income_Taxes_Details

Income Taxes (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Deferred tax assets (liabilities):
Tax credit and net operating loss carryovers	$3,191,795	$900,830
Property and equipment	-20,282	0
Research and development costs	5,820,399	845,900
Start-up and organizational costs	1,443	1,554
Stock-based compensation	448,893	647
Other accruals	188,439	90,680
Total gross deferred tax assets	9,630,687	1,839,611
Less: valuation allowance	-9,630,687	-1,839,611	-8,472
Deferred tax assets, net	$0	$0

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Tax Contingency [Line Items]
Beginning balance	$1,839,611	$8,472
Increase in valuation allowance	7,791,076	1,831,139
Ending Balance	$9,630,687	$1,839,611

Income_Taxes_Details_2

Income Taxes (Details 2)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Tax Contingency [Line Items]
Tax benefit at federal statutory rate	-34.00%	-34.00%
State income taxes	-5.80%	-5.80%
Permanent difference:
Stock-based compensation	1.10%	0.10%
Change in fair value of derivative liability	22.90%	1.30%
Amortization of debt discount	0.80%	0.00%
Gain on debt extinguishment	-1.80%	0.00%
Other	0.60%	0.00%
Federal research and development tax credit	-0.90%	0.00%
Increase in valuation allowance	17.10%	33.20%
Effective income tax rate	0.00%	0.00%
Consulting Warrant [Member]
Permanent difference:
General and administrative expense - consulting warrant	0.00%	3.90%
Financing Warrant [Member]
Permanent difference:
Derivative instrument issuance - financing warrant	0.00%	1.30%

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014
Income Tax Contingency [Line Items]
Operating Loss Carryforwards	$5,815,000
Deferred Tax Assets, Tax Credit Carryforwards, Research	$878,000
Tax Credit Carryforward Expiration Period	2032
Operating Loss Carryforwards, Limitations on Use	stock ownership of one or more 5% shareholders (shareholders owning 5% or more of the Company’s outstanding capital stock) has increased on a cumulative basis by more than 50 percentage points.

Related_Parties_Details_Textua

Related Parties (Details Textual) (USD $)	1 Months Ended	4 Months Ended	12 Months Ended
	Oct. 31, 2014	Sep. 30, 2014	Dec. 31, 2014	Oct. 04, 2013
				sqft
Office Building [Member]
Area of Land				3,562
Operating Leases, Rent Expense	$6,055	$8,548
Howard Yeatons Service [Member]
Payments for Fees			68,413
Other Financial Advisory and Accounting Services [Member]
Payments for Fees			$126,153

Subsequent_Events_Details_Text

Subsequent Events (Details Textual) (USD $)	12 Months Ended		1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Feb. 26, 2015	Jan. 28, 2015	Jan. 22, 2015
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,542,477
Lease Expiration Date		4-Jun-14
Subsequent Event [Member]
Subsequent Event [Line Items]
Proceeds from Customers				$500,000
Lease Expiration Date			30-Jun-19
Operating Leases, Rent Expense			$6,109
Subsequent Event [Member] | Employee Stock Option [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					54,500
Subsequent Event [Member] | Restricted Stock Units (RSUs) [Member] | Employee Stock Option [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			6,800
Subsequent Event [Member] | Insight Capital Consultants Corporation [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Other			15,000
Subsequent Event [Member] | Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member] | Equity Incentive Plan 2013 [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			246,226